ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2012

A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response.

Ramesh Rengan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.